Expression of C-terminal deleted p53 isoforms in neuroblastoma
Open Access
- 5 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 34 (19) , 5603-5612
- https://doi.org/10.1093/nar/gkl619
Abstract
The tumor suppressor gene, p53, is rarely mutated in neuroblastomas (NB) at the time of diagnosis, but its dysfunction could result from a nonfunctional conformation or cytoplasmic sequestration of the wild-type p53 protein. However, p53 mutation, when it occurs, is found in NB tumors with drug resistance acquired over the course of chemotherapy. As yet, no study has been devoted to the function of the specific p53 mutants identified in NB cells. This study includes characterization and functional analysis of p53 expressed in eight cell lines: three wild-type cell lines and five cell lines harboring mutations. We identified two transcription-inactive p53 variants truncated in the C-terminus, one of which corresponded to the p53β isoform recently identified in normal tissue by Bourdon et al. [J. C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville and D. P. Lane (2005) Genes Dev., 19, 2122–2137]. Our results show, for the first time, that the p53β isoform is the only p53 species to be endogenously expressed in the human NB cell line SK-N-AS, suggesting that the C-terminus truncated p53 isoforms may play an important role in NB tumor development.Keywords
This publication has 33 references indexed in Scilit:
- Reassessment of theTP53 mutation database in human disease by data mining with a library ofTP53 missense mutationsHuman Mutation, 2004
- The UMD-p53 database: New mutations and analysis toolsHuman Mutation, 2003
- ParcCell, 2003
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.2001
- p53 and Human Cancer: The First Ten Thousand MutationsPublished by Elsevier ,1999
- Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptideProceedings of the National Academy of Sciences, 1996
- Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.Proceedings of the National Academy of Sciences, 1995
- Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines.1992
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988